GSK plc (GSK) NYSE
$43.11 (0.66) (-1.51%)
Market Cap: $87.92B
As of 09/12/24 04:00 PM EDT. Market closed.
GSK plc (GSK)
NYSE
$43.11
(0.66) (-1.51%)
Market Cap: $87.92B
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ms. Emma Natasha Walmsley
Full Time Employees
70,212
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ms. Emma Natasha Walmsley
Full Time Employees
70,212
URL
Address
980 Great West Road, 980 Great West Road, Brentford, TW8 9GS.
PRICE CHART FOR GSK PLC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$43.43
Previous Close
$43.77
Days Range
$43.04 - $43.48
52 week range
$33.67 - $45.93
Volume
3,784,394
Avg. Volume (30 days)
3,478,719
Market Cap
$87.92B
Dividend Yield
2.67%
P/E
14.66
Shares Outstanding
2,039,480,000
Open
$43.43
Previous Close
$43.77
Days Range
$43.04 - $43.48
52 week range
$33.67 - $45.93
Volume
3,784,394
Avg. Volume (30 days)
3,478,719
Market Cap
$87.92B
Dividend Yield
2.67%
P/E
14.66
Shares Outstanding
2,039,480,000
FINANCIAL STATEMENTS FOR GSK PLC
LOADING...
Open in: 
Open in:
FUNDS WITH A POSITION IN GSK PLC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DODGE & COX | 68,337,138 | 1.58% | -0.76% | Value |
| FISHER ASSET MANAGEMENT, LLC | 17,706,481 | 0.3% | 13.01% | Other |
| HOLOCENE ADVISORS, LP | 5,689,695 | 0.91% | -34.75% | Growth At A Reasonable Price |
| EQUITY INVESTMENT CORP | 3,433,202 | 3.38% | 1.02% | Value |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,709,063 | 0.36% | -1.1% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 2,347,993 | 0.15% | 30.92% | Other |
| BLACKROCK INC. | 1,679,756 | 0.00146% | -6.54% | Other |
| CAPITAL RESEARCH GLOBAL INVESTORS | 1,754,493 | 0.01% | 0.08% | Growth At A Reasonable Price |
| MAGNETAR FINANCIAL LLC | 1,651,754 | 1.59% | Exited | Event Driven, Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,304,320 | 0.11% | Exited | Other |
| KAHN BROTHERS GROUP INC | 1,241,261 | 8.03% | -0.99% | Value |
| BRANDES INVESTMENT PARTNERS, LP | 1,145,512 | 0.54% | 5.63% | Value |
| BRIDGEWATER ASSOCIATES, LP | 465,826 | 0.09% | 244.31% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 11,273 | 0.00076% | -96.98% | Event Driven |
| OWL CREEK ASSET MANAGEMENT, L.P. | 193,031 | 0.87% | Exited | Event Driven, Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 70,000 (Call) | 0.00044% | New | Value |
| AQR CAPITAL MANAGEMENT LLC | 26,363 | 0.00156% | 103.42% | Other |
| GABELLI FUNDS LLC | 7,200 | 0.00211% | No change | Event Driven, Growth, Activists |
CHANGE IN SHARES OUTSTANDING FOR GSK PLC
STOCK BUYBACKS FOR GSK PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.03%
1Q
09/30/2023
0.18%
2Q
06/30/2023
0.18%
3Q
03/31/2023
-0.93%
4Q
12/31/2022
0.65%
5Q
09/30/2022
0.88%
6Q
06/30/2022
1.55%
7Q
03/31/2022
0.77%
8Q
12/31/2021
1.24%
9Q
09/30/2021
1.31%
10Q
06/30/2021
1.35%
11Q
03/31/2021
0.80%
12Q
12/31/2020
1.62%
13Q
09/30/2020
1.62%
14Q
06/30/2020
1.62%
15Q
03/31/2020
1.62%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GSK PLC
LOADING...